Wolverine (BPC-157 / TB-500 / MGF)

Wolverine is a research-use peptide blend combining BPC-157 (a synthetic pentadecapeptide derived from a gastric protein sequence), TB-500 (a synthetic fragment corresponding to the active region of Thymosin Beta-4), and MGF (Mechano Growth Factor, a splice variant of insulin-like growth factor associated with mechanical loading of tissue). The combination is cataloged under the Healing & Recovery category and is of interest to investigators studying tissue-repair, angiogenesis, and cell-migration pathways within a single multi-component reference standard. This material is supplied strictly for laboratory research and professional reference use. It is not approved by the FDA for therapeutic use, and nothing here should be read as a treatment, cure, or diagnostic claim.

Each constituent has its own distinct body of preclinical literature, and the blend is of interest to research programs examining how these mechanistically complementary peptides have been characterized individually and in combination. Individual results vary across study models, and all framing here is intended for licensed practitioners as professional reference, not patient-directed marketing.

• Investigated in preclinical literature for soft-tissue and musculoskeletal repair processes, including tendon, ligament, and muscle models
• Studied in research settings for angiogenesis and the formation of new vascular networks during tissue remodeling
• Examined in laboratory models for cell migration, fibroblast activity, and wound-site organization
• Reported in research contexts for actin cytoskeleton dynamics and inflammatory-modulation signaling
• Explored in preclinical work on mechanical-load-associated tissue adaptation and myogenic signaling pathways

For research handling reference only: typically reconstituted with bacteriostatic water (or another suitable sterile diluent per laboratory protocol), adding the diluent slowly against the vial wall rather than directly onto the lyophilized powder, and swirled gently rather than shaken to preserve peptide integrity. Lyophilized vials are generally stored frozen or refrigerated and protected from light, heat, and humidity prior to reconstitution; once reconstituted, material is commonly kept refrigerated, shielded from light, and used within a limited working window consistent with the laboratory's stability practices. Avoid repeated freeze-thaw cycles and handle under appropriate aseptic conditions. All clinical and research protocols, including any preparation parameters, concentrations, and usage decisions, are determined solely by the licensed ordering provider; this is reference information only and not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published preclinical literature, the three components are described as acting through complementary, non-identical pathways. BPC-157 has been reported in research to influence angiogenic signaling (including pathways associated with VEGF) and to modulate growth-factor and nitric-oxide-related activity relevant to cell survival and tissue organization. TB-500, as a Thymosin Beta-4 active fragment, is studied for its proposed role in binding G-actin and regulating actin polymerization, which is associated in research models with cell migration and the recruitment of repair-relevant cells. MGF, an IGF-1 splice variant, is investigated for its proposed involvement in mechanically induced signaling that has been linked in preclinical studies to satellite-cell activation and local tissue adaptation. The combined rationale studied in the literature is that these distinct mechanisms may be examined together; outcomes are model-dependent and individual results vary.